ÇѸ²´ëÇб³¼º½Éº´¿ø

±èÈ£¿µ ±³¼ö

ksfamily@hallym.or.kr
  • Àü¹®¼¾ÅÍ À¯¹æ³»ºÐºñ¾Ï¼¾ÅÍ
  • Áø·á°ú Ç÷¾×Á¾¾ç³»°ú

Àü¹®Áø·áºÐ¾ß

À¯¹æ¾Ï ¹× Æó¾Ï, ºñ´¢±â/ºÎÀΰúÁ¾¾ç, ¾Ç¼ºÈæ»öÁ¾ ¹× À°Á¾, ÇǺξÏ, ÀÏ¹Ý Ç÷¾×Áúȯ(°ñ¼öÁõ½Ä¼ºÁúȯ, ºóÇ÷ ¹× Ç÷¼ÒÆÇ Áúȯ µî)

ÀüÈ­ ¿¹¾à 1577-1801
±³¼ö´Ô»çÁø

(ÁÖ°£) Áø·á½Ã°£Ç¥ (2024-11-18 ~ 2024-11-23)

Áø·á½Ã°£Ç¥
Áø·á½Ã°£ ¿ù È­ ¼ö ¸ñ ±Ý Åä
¿ÀÀü ÈÞÁøÈÞÁøÈÞÁø
¿ÀÈÄ ÈÞÁøÈÞÁøÈÞÁø
±³¼ö´Ô »çÁø

±âº»Á¤º¸

ÇзÂ

ÇзÂ

¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇпø ÀÇÇйڻç

¿¬¼¼´ëÇб³ ¿øÁÖÄ·ÆÛ½º ÀÇ°ú´ëÇÐ ÀÇÇлç

¾ÆÁÖ´ëÇб³ ÀÇ°ú´ëÇпø ÀÇÇм®»ç

°æ·Â

°æ·Â

Çö) ÇѸ²´ëÇб³¼º½Éº´¿ø Ç÷¾×Á¾¾ç³»°ú ±³¼ö

¿¬¼¼´ëÇб³ ¿øÁÖÄ·ÆÛ½º ÀÇ°ú´ëÇÐ Á¶±³¼ö

»ï¼º¼­¿ïº´¿ø ¿¬±¸°­»ç

ÇÐȸȰµ¿

ÇÐȸȰµ¿

´ëÇÑÇ÷¾×ÇÐȸ Á¤È¸¿ø

´ëÇÑÁ¾¾ç³»°úÇÐȸ Á¤È¸¿ø

´ëÇѾÏÇÐȸ Á¤È¸¿ø

³í¹®

A Multicenter, Prospective, Observational Study to Evaluate Ethanol-Induced Symptoms in Patients Receiving Docetaxel Chemotherapy (Cancer Research and Treatment)

Treatment outcomes of advanced/metastatic extramammary Paget's disease in Korean patients: KCSG-RC20-06 (Cancer Medicine)

The Risk of Venous Thromboembolism in Korean Patients with Breast Cancer: A Single-Center Experience (CANCERS)

A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naive, high-risk essential thrombocythemia as a primary treatment (Frontiers in Oncology)

Somatic Mutations of TP53 Identified by Targeted Next-Generation Sequencing Are Poor Prognostic Factors for Primary Operable Breast Cancer: A Single-Center Study (Journal of Breast Cancer)

Clinical insights into hematologic malignancies and comparative analysis of molecular signatures of acute myeloid leukemia in different ethnicities using an artificial intelligence offering (Medicine (United States))

Treatment and Outcomes of Metastatic Pancreatic Cancer in Elderly Patients (Chemotherapy)

Prognostic effects of cytokine levels on patients treated with taxane and zoledronic acid for metastatic breast cancer in bone (BEAT-ZO) (KCSG BR 10-13) (CYTOKINE)

Awareness and Use of Complementary and Alternative Medicine in Korean Lung Cancer Patients (Tuberculosis and Respiratory Diseases)

The 2020 revision of the guidelines for the management of myeloproliferative neoplasms (The Korean Journal of Internal Medicine)